investigation-of-tgf-smad-in-blood_1920x400.jpg
Application Note

Download your application note on TGF-β SMAD α-SMA signaling in NASH

Discover the benefits of using HTRF assays to characterize liver fibrosis

Several molecular markers have been investigated as possible factors in the progression of non-alcoholic steatohepatitis (NASH) towards liver fibrosis.

The TGF-b/SMAD/α-SMA pathway has a crucial role in this progression and has emerged as an important therapeutic target.

This application note will allow you to:

  • Get an overview of the liver fibrosis mechanism’s function and dynamics
  • Take advantage of HTRF technology to study the TGF-β/SMAD/α-SMA signaling axis
  • Benefit from additional content to help you revolutionize NASH discovery

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Download your application note on TGF-β SMAD α-SMA signaling in NASH

Download Application Note